Examining the quality of treatment for opioid use disorder
Official title: Unpacking Disparities in Opioid Use Disorder Treatment Quality
Funded at Arizona State University-Tempe Campus · NIH-10886029 · Data updated 2026-11-12
This study looks at how well people with opioid use disorder are treated, especially considering differences in race, gender, and age, using health insurance data from North Carolina to find ways to make treatment better and more accessible for everyone.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Arizona State University-Tempe Campus NIH-funded |
| Lab location | 1 site (Tempe, United States) |
| Project start | September 30, 2022 |
| Project end | July 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $717,609 |
| NIH project number | 5R01DA054601-03 |
| Project ID | NIH-10886029 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals aged 21 and older who are diagnosed with opioid use disorder, especially those from racial and ethnic minority groups.
✕Less likely to help
Patients who do not have opioid use disorder or those who are not within the age range of 21 and older may not benefit from this research.
What this research studies
This research investigates the quality of treatment provided to individuals with opioid use disorder (OUD), focusing on disparities that may exist based on race, gender, and age. By analyzing real-time Medicaid claims data from North Carolina, along with Medicare and private insurance claims, the study aims to identify how treatment quality varies among different demographic groups. The goal is to understand the barriers to effective treatment and improve access to medications for opioid use disorder, which are known to reduce overdose deaths and enhance patient outcomes.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies and access for individuals suffering from opioid use disorder, particularly among underserved populations.
How similar studies have gone: Previous research has highlighted disparities in opioid treatment access and outcomes, suggesting that this approach could yield valuable insights into improving care quality.
Where this research is happening
-
Arizona State University-Tempe Campus
Tempe, United States Active
Researchers
- Principal investigator: Domino, Marisa Elena — Arizona State University-Tempe Campus
- Study coordinator: Domino, Marisa Elena
Related research
Other NIH-funded projects on the same topics.
-
Systems analysis to improve opioid use disorder care after jail release (SAIA-MOUD)
A program to help people with opioid use disorder get better, faster, and safer care after they leave jail.
-
Precise epigenetic drugs for opioid addiction
A tiny, targeted drug approach is being developed to help people with opioid use disorder by rewriting the epigenetic signals in the brain to reduce cravings and relapse risk.
-
Increasing Access to Medications for Opioid Use Disorder for Unhoused Montanans
This project helps unhoused people in Montana get life-saving medicines for opioid use disorder through clinics connected to syringe service programs, a nurse-led MOUD model, and peer support.
-
Optimizing long-acting PrEP and opioid treatment for people in jails and prisons
This project tests a real-world approach to using long-acting PrEP and buprenorphine for HIV prevention and opioid treatment among incarcerated individuals and after release.
-
Scaling up medications for opioid use disorder in residential treatment programs
This grant studies how to help residential treatment programs provide medications for opioid use disorder to reduce overdoses after discharge, focusing on real-world settings and policies.
-
Increasing Capacity at a Native Community Clinic to Improve Opioid Care for urban AI/AN
This grant helps a Native American health clinic build its research capacity to better serve urban American Indian and Alaska Native people dealing with opioid use disorder and related health issues.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.